EYEG Catches Eyes, KNSA & COVID-19, VVUS Gains Weight On Launch Of Telemedicine

Today's Daily Dose brings you news about AVEO's NDA submission for Tivozanib in renal cell carcinoma; EyeGate's encouraging data in a pilot study of dry eye; Kiniksa's progress in COVID-19 program; delay in the timeline of ProQR Therapeutics' clinical trial read-outs, near-term catalysts of Trevi; and the launch of VIVUS telemedicine portal.

from RTT - Biotech https://ift.tt/2X34dYT
via IFTTT